Speaker: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School
General Session
Speaker: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School
###Speaker: Peter Campbell – The Wellcome Trust Sanger Inst
General Session
Speaker: Peter Campbell – The Wellcome Trust Sanger Inst
###Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School
Co-Chair: Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA
General Session
Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School
Co-Chair: Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA
General Session
Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School
### @@@ Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA ### 1395145###Co-Chair###Professor of Medicine, Director of the Center for Blood Cancers Director of the Clinical Myeloma Pro###Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA###Co-Chair: Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA
### she/her/hersSpeaker: Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA
General Session
Speaker: Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA
### she/her/hersSpeaker: Karin Vanderkerken, PhD (she/her/hers) – Vrije Universiteit Brusssels
General Session
Speaker: Karin Vanderkerken, PhD (she/her/hers) – Vrije Universiteit Brusssels
### she/her/hersSpeaker: Madhav V. Dhodapkar, MD, MBBS (he/him/his) – Winship Cancer Institute, Emory University, Atlanta, GA, USA
General Session
Speaker: Madhav V. Dhodapkar, MD, MBBS (he/him/his) – Winship Cancer Institute, Emory University, Atlanta, GA, USA
### he/him/hisSpeaker: Sigurdur Y. Kristinsson, MD, PhD – University of Iceland
General Session
Speaker: Sigurdur Y. Kristinsson, MD, PhD – University of Iceland
###Speaker: Anthony Cirrincione, PhD – Myeloma Service, Sylvester Comprehensive Cancer Center, University of Miami
General Session
Speaker: Anthony Cirrincione, PhD – Myeloma Service, Sylvester Comprehensive Cancer Center, University of Miami
###Speaker: Wen Zhou, PhD – Cancer Research Institute, Xiangya School of Medicine, Central South University
General Session
Speaker: Wen Zhou, PhD – Cancer Research Institute, Xiangya School of Medicine, Central South University
###Speaker: Rodger E. Tiedemann, MD, PhD (he/him/his) – Princess Margaret Cancer Centre
General Session
Speaker: Rodger E. Tiedemann, MD, PhD (he/him/his) – Princess Margaret Cancer Centre
### he/him/hisSpeaker: Leif Bergsagel, MD – Mayo Clinic Arizona
General Session
Speaker: Leif Bergsagel, MD – Mayo Clinic Arizona
###Panelist: Rafael Fonseca, MD – Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA
Panelist: Andrew Spencer, MBBS FRACP, FRCPA, DM – Alfred Health-Monash University
Panelist: Rodger E. Tiedemann, MD, PhD (he/him/his) – Princess Margaret Cancer Centre
Panelist: Marta Chesi, PhD (she/her/hers) – Mayo Clinic Arizona
General Session
Panelist: Rafael Fonseca, MD – Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA
### @@@ Andrew Spencer, MBBS FRACP, FRCPA, DM – Alfred Health-Monash University ### 1441802###Panelist###Professor###Alfred Health-Monash University###Panelist: Andrew Spencer, MBBS FRACP, FRCPA, DM – Alfred Health-Monash University
### @@@ Rodger E. Tiedemann, MD, PhD (he/him/his) – Princess Margaret Cancer Centre ### 1395134###Panelist###Senior Scientist, Hematologist###Princess Margaret Cancer Centre###Panelist: Rodger E. Tiedemann, MD, PhD (he/him/his) – Princess Margaret Cancer Centre
### he/him/his @@@ Marta Chesi, PhD (she/her/hers) – Mayo Clinic Arizona ### 1395120###Panelist###Associate Professor###Mayo Clinic Arizona###Panelist: Marta Chesi, PhD (she/her/hers) – Mayo Clinic Arizona
### she/her/hersCo-Chair: Monica Morris, MSc, RN – Myeloma UK
Co-Chair: Ioanna Tsatsou
Nursing & Allied Health Symposium
Co-Chair: Monica Morris, MSc, RN – Myeloma UK
Co-Chair: Ioanna Tsatsou
Nursing & Allied Health Symposium
Co-Chair: Monica Morris, MSc, RN – Myeloma UK
### @@@ Ioanna Tsatsou ### 1996608###Co-Chair#########Co-Chair: Ioanna Tsatsou
###Co-Chair: Monica Morris, MSc, RN – Myeloma UK
Co-Chair: Ioanna Tsatsou
Nursing & Allied Health Symposium
Co-Chair: Monica Morris, MSc, RN – Myeloma UK
### @@@ Ioanna Tsatsou ### 1996608###Co-Chair#########Co-Chair: Ioanna Tsatsou
###Speaker: Evangelos Terpos, MD, PhD (he/him/his) – Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece
Nursing & Allied Health Symposium
Speaker: Evangelos Terpos, MD, PhD (he/him/his) – Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece
### he/him/hisSpeaker: Gordon Cook, PhD – Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK
Nursing & Allied Health Symposium
Speaker: Gordon Cook, PhD – Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK
###Speaker: Jessica Chen, MS, FNP – MD Anderson Cancer Center
Nursing & Allied Health Symposium
Speaker: Jessica Chen, MS, FNP – MD Anderson Cancer Center
###Speaker: Donna D. Catamero, ANP-BC – Mount Sinai Hospital
Nursing & Allied Health Symposium
Speaker: Donna D. Catamero, ANP-BC – Mount Sinai Hospital
###Speaker: Chloe Ray, AGPCNP-BC, OCN – Mount Sinai Hospital
Nursing & Allied Health Symposium
Speaker: Chloe Ray, AGPCNP-BC, OCN – Mount Sinai Hospital
###Co-Chair: Beth Faiman, PhD, MSN, APN-BC,BMTCN, AOCN, FAAN, FAPO – Cleveland Clinic Taussig Cancer Institute, Department of Hematology and Medical Oncology
Co-Chair: Matthias Hellberg-Naegele, MSc – Comprehensive Cancer Center Zurich
Nursing & Allied Health Symposium
Co-Chair: Beth Faiman, PhD, MSN, APN-BC,BMTCN, AOCN, FAAN, FAPO – Cleveland Clinic Taussig Cancer Institute, Department of Hematology and Medical Oncology
Co-Chair: Matthias Hellberg-Naegele, MSc – Comprehensive Cancer Center Zurich
Nursing & Allied Health Symposium
Co-Chair: Beth Faiman, PhD, MSN, APN-BC,BMTCN, AOCN, FAAN, FAPO – Cleveland Clinic Taussig Cancer Institute, Department of Hematology and Medical Oncology
### @@@ Matthias Hellberg-Naegele, MSc – Comprehensive Cancer Center Zurich ### 1409002###Co-Chair###Clinical Nurse Specialist###Comprehensive Cancer Center Zurich###Co-Chair: Matthias Hellberg-Naegele, MSc – Comprehensive Cancer Center Zurich
###Speaker: Orla McCourt, PhD MCSP – University College London NHS Foundation Trust
Nursing & Allied Health Symposium
Speaker: Orla McCourt, PhD MCSP – University College London NHS Foundation Trust
###Speaker: Joanne S. Land, BSc (she/her/hers) – NHS University College London Hospital, London, United Kingdom
Nursing & Allied Health Symposium
Speaker: Joanne S. Land, BSc (she/her/hers) – NHS University College London Hospital, London, United Kingdom
### she/her/hersSpeaker: Emma Dowling, RN BSC – HCA Healthcare UK
Nursing & Allied Health Symposium
Speaker: Emma Dowling, RN BSC – HCA Healthcare UK
###Speaker: Houry Leblebjian
Nursing & Allied Health Symposium
Speaker: Houry Leblebjian
###Speaker: Charise Gleason, NP-C – Winship Cancer Institute of Emory University
Nursing & Allied Health Symposium
Speaker: Charise Gleason, NP-C – Winship Cancer Institute of Emory University
###Industry Symposium
Industry Symposium
Speaker: Hermann Einsele, MD, FRCP (he/him/his) – Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany
Industry Symposium
Speaker: Hermann Einsele, MD, FRCP (he/him/his) – Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany
### he/him/hisSpeaker: Hermann Einsele, MD, FRCP (he/him/his) – Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany
Industry Symposium
Speaker: Hermann Einsele, MD, FRCP (he/him/his) – Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany
### he/him/hisSpeaker: Yi Lin, MD, PHD – Mayo Clinic, Rochester, MN, USA
Industry Symposium
Speaker: Yi Lin, MD, PHD – Mayo Clinic, Rochester, MN, USA
###Speaker: Bruno Paiva, PhD – Clínica Universidad de Navarra (CUN), Centro de Investigación Médica Aplicada (CIMA LAB Diagnostics), IDISNA, CIBERONC
Industry Symposium
Speaker: Bruno Paiva, PhD – Clínica Universidad de Navarra (CUN), Centro de Investigación Médica Aplicada (CIMA LAB Diagnostics), IDISNA, CIBERONC
###Speaker: Rakesh Popat, MD, PhD – University College London Hospitals NHS Foundation Trust
Industry Symposium
Speaker: Rakesh Popat, MD, PhD – University College London Hospitals NHS Foundation Trust
###Chair: Rakesh Popat, MD, PhD – University College London Hospitals NHS Foundation Trust
Industry Symposium
Chair: Rakesh Popat, MD, PhD – University College London Hospitals NHS Foundation Trust
###Nursing & Allied Health Symposium
Nursing & Allied Health Symposium
Co-Chair: Tiffany Richards
### @@@ Andrea D. Preston, MRPharmS (Consultant) (she/her/hers) – NHS / Sanius Health ### 1998508###Co-Chair###Myeloma Specialist Pharmacist / Head of Patient Innovation & Care###NHS / Sanius Health###Co-Chair: Andrea D. Preston, MRPharmS (Consultant) (she/her/hers) – NHS / Sanius Health
### she/her/hersSpeaker: Tracy King, PhD, MN, RN – Royal Prince Alfred Hospital, The University of Sydney
Nursing & Allied Health Symposium
Speaker: Tracy King, PhD, MN, RN – Royal Prince Alfred Hospital, The University of Sydney
###Speaker: Monica Morris, MSc, RN – Myeloma UK
Nursing & Allied Health Symposium
Speaker: Monica Morris, MSc, RN – Myeloma UK
###Speaker: Urvi A. Shah, MD (she/her/hers) – Myeloma Service, Memorial Sloan Kettering Cancer Center
Nursing & Allied Health Symposium
Speaker: Urvi A. Shah, MD (she/her/hers) – Myeloma Service, Memorial Sloan Kettering Cancer Center
### she/her/hersSpeaker: Rebecca Lu, MSN, FNP-C – MD Anderson
Nursing & Allied Health Symposium
Speaker: Rebecca Lu, MSN, FNP-C – MD Anderson
###Speaker: Tracy King, PhD, MN, RN – Royal Prince Alfred Hospital, The University of Sydney
Nursing & Allied Health Symposium
Speaker: Tracy King, PhD, MN, RN – Royal Prince Alfred Hospital, The University of Sydney
###Chair: Maria-Victoria Mateos, PhD (she/her/hers) – University Hospital of Salamanca
Co-Chair: S. Vincent Rajkumar, MD – Mayo Clinic
General Session
Chair: Maria-Victoria Mateos, PhD (she/her/hers) – University Hospital of Salamanca
Co-Chair: S. Vincent Rajkumar, MD – Mayo Clinic
General Session
Chair: Maria-Victoria Mateos, PhD (she/her/hers) – University Hospital of Salamanca
### she/her/hers @@@ S. Vincent Rajkumar, MD – Mayo Clinic ### 1949877###Co-Chair###Edward W. and Betty Knight Scripps Professor of Medicine###Mayo Clinic###Co-Chair: S. Vincent Rajkumar, MD – Mayo Clinic
###Speaker: Saad Z. Usmani, MD MBA FACP – Memorial Sloan Kettering Cancer Center
General Session
Speaker: Saad Z. Usmani, MD MBA FACP – Memorial Sloan Kettering Cancer Center
###Speaker: Aurore Perrot, MD, PhD – CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France
General Session
Speaker: Aurore Perrot, MD, PhD – CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France
###Speaker: Kwee L. Yong, PhD (she/her/hers) – University College London Cancer Institute, London, UK
General Session
Speaker: Kwee L. Yong, PhD (she/her/hers) – University College London Cancer Institute, London, UK
### she/her/hersSpeaker: Evangelos Terpos, MD, PhD (he/him/his) – Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece
General Session
Speaker: Evangelos Terpos, MD, PhD (he/him/his) – Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece
### he/him/hisSpeaker: Thomas Lund, MD, PhD (he/him/his) – Department of Hematology Odense University Hospital
General Session
Speaker: Thomas Lund, MD, PhD (he/him/his) – Department of Hematology Odense University Hospital
### he/him/hisSpeaker: Lisa B. Leypoldt, MD (she/her/hers) – University Medical Center Hamburg-Eppendorf, Germany / Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Department of Medicine, Harvard Medical School, Boston, MA, USA. Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA. Department of Hematology, Oncology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
General Session
Speaker: Lisa B. Leypoldt, MD (she/her/hers) – University Medical Center Hamburg-Eppendorf, Germany / Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Department of Medicine, Harvard Medical School, Boston, MA, USA. Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA. Department of Hematology, Oncology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
### she/her/hersSpeaker: Panagiotis Malandrakis, MD (he/him/his) – Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
General Session
Speaker: Panagiotis Malandrakis, MD (he/him/his) – Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
### he/him/hisSpeaker: S. Vincent Rajkumar, MD – Mayo Clinic
General Session
Speaker: S. Vincent Rajkumar, MD – Mayo Clinic
###Panelist: Sergio Giralt, MD – Memorial Sloan Kettering Cancer Center
Panelist: Thierry Facon, MD – University of Lille, CHU Lille, Service des Maladies du Sang, Lille, France
Panelist: Jean-Luc Harousseau, MD – INSTITUT DE CANCEROLOGIE DE L'OUEST FRANCE
Panelist: Vania Hungria, MD, PhD – Department of Hematology, Clinica São Germano, São Paulo, Brazil
Panelist: Michele Cavo (he/him/his) – IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Università degli Studi di Bologna, Bologna, Italy
Panelist: Bindu Kanapuru
General Session
Panelist: Sergio Giralt, MD – Memorial Sloan Kettering Cancer Center
### @@@ Thierry Facon, MD – University of Lille, CHU Lille, Service des Maladies du Sang, Lille, France ### 1395081###Panelist###Pr###University of Lille, CHU Lille, Service des Maladies du Sang, Lille, France###Panelist: Thierry Facon, MD – University of Lille, CHU Lille, Service des Maladies du Sang, Lille, France
### @@@ Jean-Luc Harousseau, MD – INSTITUT DE CANCEROLOGIE DE L'OUEST FRANCE ### 1395104###Panelist###SCIENTIFIC DIRECTOR###INSTITUT DE CANCEROLOGIE DE L'OUEST FRANCE###Panelist: Jean-Luc Harousseau, MD – INSTITUT DE CANCEROLOGIE DE L'OUEST FRANCE
### @@@ Vania Hungria, MD, PhD – Department of Hematology, Clinica São Germano, São Paulo, Brazil ### 1395161###Panelist###Associate Professor###Department of Hematology, Clinica São Germano, São Paulo, Brazil###Panelist: Vania Hungria, MD, PhD – Department of Hematology, Clinica São Germano, São Paulo, Brazil
### @@@ Michele Cavo (he/him/his) – IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Università degli Studi di Bologna, Bologna, Italy ### 1395079###Panelist###Professor of Haematology###IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Università degli Studi di Bologna, Bologna, Italy###Panelist: Michele Cavo (he/him/his) – IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Università degli Studi di Bologna, Bologna, Italy
### he/him/his @@@ Bindu Kanapuru ### 2102754###Panelist#########Panelist: Bindu Kanapuru
###Co-Chair: Morie A. Gertz, MD, MACP (he/him/his) – Mayo Clinic
Co-Chair: Hartmut Goldschmidt, MD – Department of Medicine V, University Hospital Heidelberg; and National Center for Tumor Diseases (NCT)
Oral Abstract Session
Co-Chair: Morie A. Gertz, MD, MACP (he/him/his) – Mayo Clinic
Co-Chair: Hartmut Goldschmidt, MD – Department of Medicine V, University Hospital Heidelberg; and National Center for Tumor Diseases (NCT)
Oral Abstract Session
Co-Chair: Morie A. Gertz, MD, MACP (he/him/his) – Mayo Clinic
### he/him/his @@@ Hartmut Goldschmidt, MD – Department of Medicine V, University Hospital Heidelberg; and National Center for Tumor Diseases (NCT) ### 1441836###Co-Chair###Head of the GMMG Studygroup, Department of Medicine V### Department of Medicine V, University Hospital Heidelberg; and National Center for Tumor Diseases (NCT)###Co-Chair: Hartmut Goldschmidt, MD – Department of Medicine V, University Hospital Heidelberg; and National Center for Tumor Diseases (NCT)
###Speaker: Camila Guerrero – Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), CIBER-ONC number CB16/12/00369
Oral Abstract Session
Speaker: Camila Guerrero – Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), CIBER-ONC number CB16/12/00369
###Speaker: Annika Werly – Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
Oral Abstract Session
Speaker: Annika Werly – Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
###Speaker: Charan T R Vegivinti, MD (he/him/his) – Jacobi Medical Center / Albert Einstein College of Medicine
Oral Abstract Session
Speaker: Charan T R Vegivinti, MD (he/him/his) – Jacobi Medical Center / Albert Einstein College of Medicine
### he/him/hisSpeaker: Jens Hillengass, MD, PhD – Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
Oral Abstract Session
Speaker: Jens Hillengass, MD, PhD – Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
###Speaker: Albert Oriol, PhD (he/him/his) – Catalan Institute of Oncology and Josep Carreras Institute, Hospital Germans Trias i Pujol, Badalona, Spain
Oral Abstract Session
Speaker: Albert Oriol, PhD (he/him/his) – Catalan Institute of Oncology and Josep Carreras Institute, Hospital Germans Trias i Pujol, Badalona, Spain
### he/him/hisCo-Chair: Annemiek Broijl, MD, PhD (she/her/hers) – ErasmusMC
Co-Chair: Lugui Qiu, MD (he/him/his) – Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences.
Oral Abstract Session
Co-Chair: Annemiek Broijl, MD, PhD (she/her/hers) – ErasmusMC
Co-Chair: Lugui Qiu, MD (he/him/his) – Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences.
Oral Abstract Session
Co-Chair: Annemiek Broijl, MD, PhD (she/her/hers) – ErasmusMC
### she/her/hers @@@ Lugui Qiu, MD (he/him/his) – Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences. ### 1409100###Co-Chair###Department Head###Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences.###Co-Chair: Lugui Qiu, MD (he/him/his) – Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences.
### he/him/hisSpeaker: Elizabeth D. Lightbody, PhD – Dana-Farber Cancer Institute
Oral Abstract Session
Speaker: Elizabeth D. Lightbody, PhD – Dana-Farber Cancer Institute
###Speaker: Afsaneh Panahi, MSc – BC Cancer Research Centre/ University of British Columbia
Oral Abstract Session
Speaker: Afsaneh Panahi, MSc – BC Cancer Research Centre/ University of British Columbia
###Speaker: wei tan, Ph.D – The University of Texas MD Anderson Cancer Center
Oral Abstract Session
Speaker: wei tan, Ph.D – The University of Texas MD Anderson Cancer Center
###Speaker: Frits van Rhee, MD PHD (he/him/his) – Myeloma Center, University of Arkansas of Medicine
Oral Abstract Session
Speaker: Frits van Rhee, MD PHD (he/him/his) – Myeloma Center, University of Arkansas of Medicine
### he/him/hisSpeaker: Hao Mu, Principle Investigation (she/her/hers) – State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Oral Abstract Session
Speaker: Hao Mu, Principle Investigation (she/her/hers) – State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
### she/her/hersSpeaker: S. Vincent Rajkumar, MD – Mayo Clinic
Speaker: Siddhartha Mukherjee
Speaker: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA
General Session
Speaker: S. Vincent Rajkumar, MD – Mayo Clinic
Speaker: Siddhartha Mukherjee
Speaker: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA
General Session
Speaker: S. Vincent Rajkumar, MD – Mayo Clinic
### @@@ Siddhartha Mukherjee ### 1957007###Speaker#########Speaker: Siddhartha Mukherjee
### @@@ Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA ### 1395113###Speaker###Professor and Chair###Emory University School of Medicine, Atlanta, GA, USA###Speaker: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA
###Speaker: Marc S. Raab, MD (he/him/his) – Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany and Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
Speaker: Charlotte Pawlyn, PhD, FRCP, FRCPath – The Institute of Cancer Research
Career Development
Speaker: Marc S. Raab, MD (he/him/his) – Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany and Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
### he/him/his @@@ Charlotte Pawlyn, PhD, FRCP, FRCPath – The Institute of Cancer Research ### 1395074###Speaker###Research Team Leader and Consultant Haematologist###The Institute of Cancer Research###Speaker: Charlotte Pawlyn, PhD, FRCP, FRCPath – The Institute of Cancer Research
###Speaker: Enrique M. Ocio, MD, PhD – Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain
Speaker: Adam S. Sperling, MD, PhD (he/him/his) – Brigham and Women's Hospital
Meet the Professor
Speaker: Enrique M. Ocio, MD, PhD – Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain
### @@@ Adam S. Sperling, MD, PhD (he/him/his) – Brigham and Women's Hospital ### 1395133###Speaker###Assistant Professor###Brigham and Women's Hospital###Speaker: Adam S. Sperling, MD, PhD (he/him/his) – Brigham and Women's Hospital
### he/him/hisSpeaker: Ashutosh D. Wechalekar, MD – University College Hospital
Speaker: Vaishali Sanchorawala, MD (she/her/hers) – Boston University Chobanian & Avedisian School of Medicine
Meet the Professor
Speaker: Ashutosh D. Wechalekar, MD – University College Hospital
### @@@ Vaishali Sanchorawala, MD (she/her/hers) – Boston University Chobanian & Avedisian School of Medicine ### 1395067###Speaker###Director, Amyloidosis Center,### Boston University Chobanian & Avedisian School of Medicine###Speaker: Vaishali Sanchorawala, MD (she/her/hers) – Boston University Chobanian & Avedisian School of Medicine
### she/her/hersSpeaker: Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center
Meet the Professor
Speaker: Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center
###Speaker: Efstathios Kastritis, MD, PhD (he/him/his) – National and Kapodistrian University of Athens
Speaker: Pankaj Malhorta, MD – Postgraduate Institute of Medical Education and Research
Meet the Professor
Speaker: Efstathios Kastritis, MD, PhD (he/him/his) – National and Kapodistrian University of Athens
### he/him/his @@@ Pankaj Malhorta, MD – Postgraduate Institute of Medical Education and Research ### 1949879###Speaker###Professor and Head###Postgraduate Institute of Medical Education and Research###Speaker: Pankaj Malhorta, MD – Postgraduate Institute of Medical Education and Research
###Speaker: Elena Zamagni, Sr., MD, PhD (she/her/hers) – European Myeloma Network, Italy
Speaker: Jens Hillengass, MD, PhD – Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
Meet the Professor
Speaker: Elena Zamagni, Sr., MD, PhD (she/her/hers) – European Myeloma Network, Italy
### she/her/hers @@@ Jens Hillengass, MD, PhD – Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA ### 1409085###Speaker###Professor of Oncology and Internal Medicine###Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA###Speaker: Jens Hillengass, MD, PhD – Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
###Speaker: Lalit Kumar, MD, DM (he/him/his) – Oncology and BMT, Artemis Hospitals, Gurugram122001, India
Speaker: Craig E. Cole, MD – Michigan State University-Karmanos Cancer Institute
Meet the Professor
Speaker: Lalit Kumar, MD, DM (he/him/his) – Oncology and BMT, Artemis Hospitals, Gurugram122001, India
### he/him/his @@@ Craig E. Cole, MD – Michigan State University-Karmanos Cancer Institute ### 1395102###Speaker###Assistant Professor###Michigan State University-Karmanos Cancer Institute###Speaker: Craig E. Cole, MD – Michigan State University-Karmanos Cancer Institute
###Speaker: Nelson Leung, MD – Division of hematology and Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN
Meet the Professor
Speaker: Nelson Leung, MD – Division of hematology and Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN
###Co-Chair: Pieter Sonneveld, MD, PhD (he/him/his) – EMN
Co-Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School
General Session
Co-Chair: Pieter Sonneveld, MD, PhD (he/him/his) – EMN
Co-Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School
General Session
Co-Chair: Pieter Sonneveld, MD, PhD (he/him/his) – EMN
### he/him/his @@@ Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School ### 1395035###Co-Chair###Kraft Family Chair, Director of Basic and Correlative Science, Professor of Medicine, Harvard Medical School ###Dana-Farber Cancer Institute, Harvard Medical School###Co-Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School
###Speaker: Paolo Ghia, MD. PhD (he/him/his) – Università Vita-Salute San Raffaele
General Session
Speaker: Paolo Ghia, MD. PhD (he/him/his) – Università Vita-Salute San Raffaele
### he/him/hisSpeaker: Jacqueline Cloos, PhD (she/her/hers) – Amsterdam UMC, location VUMC, Cancer Center Amsterdam
General Session
Speaker: Jacqueline Cloos, PhD (she/her/hers) – Amsterdam UMC, location VUMC, Cancer Center Amsterdam
### she/her/hersSpeaker: Nicole Gormley, MD – U.S. Food and Drug Administration
General Session
Speaker: Nicole Gormley, MD – U.S. Food and Drug Administration
###Chair: Kenneth C. Anderson, MD – The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Co-Chair: Gareth Morgan, MD, PHD, FRCP, FRCPATH (he/him/his) – NYU Langone Health Perlmutter Cancer Center
General Session
Chair: Kenneth C. Anderson, MD – The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Co-Chair: Gareth Morgan, MD, PHD, FRCP, FRCPATH (he/him/his) – NYU Langone Health Perlmutter Cancer Center
General Session
Chair: Kenneth C. Anderson, MD – The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
### @@@ Gareth Morgan, MD, PHD, FRCP, FRCPATH (he/him/his) – NYU Langone Health Perlmutter Cancer Center ### 1395144###Co-Chair###Professor of Medicine, Director of Myeloma Research###NYU Langone Health Perlmutter Cancer Center###Co-Chair: Gareth Morgan, MD, PHD, FRCP, FRCPATH (he/him/his) – NYU Langone Health Perlmutter Cancer Center
### he/him/hisSpeaker: Irene Ghobrial, MD (she/her/hers) – Dana-Farber Cancer Institute, Boston, MA, USA
General Session
Speaker: Irene Ghobrial, MD (she/her/hers) – Dana-Farber Cancer Institute, Boston, MA, USA
### she/her/hersSpeaker: Mala Shanmugam, MS, PhD (she/her/hers) – Winship Cancer Institute, Emory University
General Session
Speaker: Mala Shanmugam, MS, PhD (she/her/hers) – Winship Cancer Institute, Emory University
### she/her/hersSpeaker: Felipe Prosper, MD (he/him/his) – Clinica Universidad de Navarra
General Session
Speaker: Felipe Prosper, MD (he/him/his) – Clinica Universidad de Navarra
### he/him/hisSpeaker: Arun P. Wiita, MD, PhD – University of California San Francisco, San Francisco, CA, USA
General Session
Speaker: Arun P. Wiita, MD, PhD – University of California San Francisco, San Francisco, CA, USA
###Speaker: Maximilian Merz, MD (he/him/his) – University of Leipzig
General Session
Speaker: Maximilian Merz, MD (he/him/his) – University of Leipzig
### he/him/hisSpeaker: Laura Lucia Cogrossi – San Raffaele Scientific Institute
General Session
Speaker: Laura Lucia Cogrossi – San Raffaele Scientific Institute
###Speaker: Andrea Poletti, PhD – IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli” - Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy
General Session
Speaker: Andrea Poletti, PhD – IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli” - Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy
###Speaker: Gareth Morgan, MD, PHD, FRCP, FRCPATH (he/him/his) – NYU Langone Health Perlmutter Cancer Center
General Session
Speaker: Gareth Morgan, MD, PHD, FRCP, FRCPATH (he/him/his) – NYU Langone Health Perlmutter Cancer Center
### he/him/hisPanelist: Sonja Zweegman, MD, PhD – Amsterdam UMC
Panelist: Herve Avet-Loiseau, MD, PhD (he/him/his) – IUC-Oncopole
Panelist: Wilson I. Gonsalves, MD – Mayo Clinic, Rochester
Panelist: Jill CORRE, PharmD, PhD (she/her/hers) – Institut Universitaire du Cancer de Toulouse-Oncopole
General Session
Panelist: Sonja Zweegman, MD, PhD – Amsterdam UMC
### @@@ Herve Avet-Loiseau, MD, PhD (he/him/his) – IUC-Oncopole ### 1395049###Panelist###Head###IUC-Oncopole###Panelist: Herve Avet-Loiseau, MD, PhD (he/him/his) – IUC-Oncopole
### he/him/his @@@ Wilson I. Gonsalves, MD – Mayo Clinic, Rochester ### 1395132###Panelist###Consultant, Division of Hematology, Department of Internal Medicine###Mayo Clinic, Rochester###Panelist: Wilson I. Gonsalves, MD – Mayo Clinic, Rochester
### @@@ Jill CORRE, PharmD, PhD (she/her/hers) – Institut Universitaire du Cancer de Toulouse-Oncopole ### 1395043###Panelist###Professor###Institut Universitaire du Cancer de Toulouse-Oncopole###Panelist: Jill CORRE, PharmD, PhD (she/her/hers) – Institut Universitaire du Cancer de Toulouse-Oncopole
### she/her/hersChair: Michel Delforge, MD/Phd – University of Leuven, Leuven, Belgium
Industry Symposium
Chair: Michel Delforge, MD/Phd – University of Leuven, Leuven, Belgium
Industry Symposium
Chair: Michel Delforge, MD/Phd – University of Leuven, Leuven, Belgium
###Chair: Michel Delforge, MD/Phd – University of Leuven, Leuven, Belgium
Industry Symposium
Chair: Michel Delforge, MD/Phd – University of Leuven, Leuven, Belgium
###Speaker: Leo Rasche, MD – Department of Internal Medicine II, University Hospital, 97080 Würzburg, Germany
Industry Symposium
Speaker: Leo Rasche, MD – Department of Internal Medicine II, University Hospital, 97080 Würzburg, Germany
###Speaker: Michel Delforge, MD/Phd – University of Leuven, Leuven, Belgium
Industry Symposium
Speaker: Michel Delforge, MD/Phd – University of Leuven, Leuven, Belgium
###Speaker: Roberto Mina, MD – European Myeloma Network, Italy
Industry Symposium
Speaker: Roberto Mina, MD – European Myeloma Network, Italy
###Chair: Philippe Moreau, MD – University Hospital Hôtel-Dieu, Nantes, France
Co-Chair: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA
General Session
Chair: Philippe Moreau, MD – University Hospital Hôtel-Dieu, Nantes, France
Co-Chair: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA
General Session
Chair: Philippe Moreau, MD – University Hospital Hôtel-Dieu, Nantes, France
### @@@ Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA ### 1395113###Co-Chair###Professor and Chair###Emory University School of Medicine, Atlanta, GA, USA###Co-Chair: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA
###Speaker: Nizar J. Bahlis, MD – Arnie Charbonneau Cancer Institute - University of Calgary
General Session
Speaker: Nizar J. Bahlis, MD – Arnie Charbonneau Cancer Institute - University of Calgary
###Speaker: Lawrence Boise, PhD (he/him/his) – Emory University
General Session
Speaker: Lawrence Boise, PhD (he/him/his) – Emory University
### he/him/hisSpeaker: Suzanne Lentzsch, MD, PhD (she/her/hers) – Columbia University
General Session
Speaker: Suzanne Lentzsch, MD, PhD (she/her/hers) – Columbia University
### she/her/hersSpeaker: Paula Rodriguez-Otero, MD PhD (she/her/hers) – Clinica Universidad de Navarra
General Session
Speaker: Paula Rodriguez-Otero, MD PhD (she/her/hers) – Clinica Universidad de Navarra
### she/her/hersSpeaker: Shuntaro Ikegawa, MD, PhD – Dana-Farber Cancer Institute
General Session
Speaker: Shuntaro Ikegawa, MD, PhD – Dana-Farber Cancer Institute
###Speaker: Alexandra M. Poos, PhD (she/her/hers) – Multiple Myeloma Section, Department of Medicine V, University Hospital Heidelberg
General Session
Speaker: Alexandra M. Poos, PhD (she/her/hers) – Multiple Myeloma Section, Department of Medicine V, University Hospital Heidelberg
### she/her/hersSpeaker: Leo Rasche, MD – Department of Internal Medicine II, University Hospital, 97080 Würzburg, Germany
General Session
Speaker: Leo Rasche, MD – Department of Internal Medicine II, University Hospital, 97080 Würzburg, Germany
###Speaker: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA
General Session
Speaker: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA
###Panelist: P. Joy Ho, MBBS DPhil FRACP FRCPA (she/her/hers) – Institute of Haematology, Royal Prince Alfred Hospital
Panelist: Keith Stewart, MB ChB – Princess Margaret Cancer Centre, University Health Network
Panelist: MELETIOS DIMOPOULOS, MD (he/him/his) – Department of Clinical Therapeutics/Medical School/National and Kapodistrian University of Athens
Panelist: Donna E. Reece, MD – University Health Network, Princess Margaret Cancer Centre
Panelist: Ajai Chari, MD, PhD – Icahn School of Medicine at Mount Sinai, New York, NY, USA
Panelist: Bindu Kanapuru
General Session
Panelist: P. Joy Ho, MBBS DPhil FRACP FRCPA (she/her/hers) – Institute of Haematology, Royal Prince Alfred Hospital
### she/her/hers @@@ Keith Stewart, MB ChB – Princess Margaret Cancer Centre, University Health Network ### 1395117###Panelist###Medical Director, Princess Margaret Cancer Centre and VP Cancer, University Health Network###Princess Margaret Cancer Centre, University Health Network###Panelist: Keith Stewart, MB ChB – Princess Margaret Cancer Centre, University Health Network
### @@@ MELETIOS DIMOPOULOS, MD (he/him/his) – Department of Clinical Therapeutics/Medical School/National and Kapodistrian University of Athens ### 1949885###Panelist###Professor###Department of Clinical Therapeutics/Medical School/National and Kapodistrian University of Athens###Panelist: MELETIOS DIMOPOULOS, MD (he/him/his) – Department of Clinical Therapeutics/Medical School/National and Kapodistrian University of Athens
### he/him/his @@@ Donna E. Reece, MD – University Health Network, Princess Margaret Cancer Centre ### 1395149###Panelist###Professor of Medicine, Director, Clinical Trials Program for Multiple Myeloma and Related Diseases###University Health Network, Princess Margaret Cancer Centre###Panelist: Donna E. Reece, MD – University Health Network, Princess Margaret Cancer Centre
### @@@ Ajai Chari, MD, PhD – Icahn School of Medicine at Mount Sinai, New York, NY, USA ### 1395089###Panelist###Professor of Medicine, Hematology, and Oncology###Icahn School of Medicine at Mount Sinai, New York, NY, USA###Panelist: Ajai Chari, MD, PhD – Icahn School of Medicine at Mount Sinai, New York, NY, USA
### @@@ Bindu Kanapuru ### 2102754###Panelist#########Panelist: Bindu Kanapuru
###Co-Chair: Gordon Cook, PhD – Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK
Co-Chair: Eirini Katodritou, MD, PhD (she/her/hers) – Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece
Oral Abstract Session
Co-Chair: Gordon Cook, PhD – Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK
Co-Chair: Eirini Katodritou, MD, PhD (she/her/hers) – Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece
Oral Abstract Session
Co-Chair: Gordon Cook, PhD – Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK
### @@@ Eirini Katodritou, MD, PhD (she/her/hers) – Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece ### 1442719###Co-Chair###Hematology Consultant###Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece###Co-Chair: Eirini Katodritou, MD, PhD (she/her/hers) – Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece
### she/her/hersSpeaker: Darrell White, MD (he/him/his) – Dalhousie University and Queen Elizabeth II Health Sciences Centre
Oral Abstract Session
Speaker: Darrell White, MD (he/him/his) – Dalhousie University and Queen Elizabeth II Health Sciences Centre
### he/him/hisSpeaker: Jonathan L. Kaufman, MD – Winship Cancer Institute of Emory University
Oral Abstract Session
Speaker: Jonathan L. Kaufman, MD – Winship Cancer Institute of Emory University
###Speaker: Meral Beksac, MD (she/her/hers) – Ankara University
Oral Abstract Session
Speaker: Meral Beksac, MD (she/her/hers) – Ankara University
### she/her/hersSpeaker: Samer Al Hadidi, MD,MS,FACP – the University of Arkansas for Medical Sciences
Oral Abstract Session
Speaker: Samer Al Hadidi, MD,MS,FACP – the University of Arkansas for Medical Sciences
###Speaker: Cyrille Touzeau, MD, PhD – CHU Nantes
Oral Abstract Session
Speaker: Cyrille Touzeau, MD, PhD – CHU Nantes
###Co-Chair: Masood A. Shammas, PhD – Dana Farber Cancer Institute and VA Boston Healthcare System, Boston, MA, USA
Co-Chair: Mark Bustoros, MD – Meyer Cancer Center, Weill Cornell Medicine, Cornell University
Oral Abstract Session
Co-Chair: Masood A. Shammas, PhD – Dana Farber Cancer Institute and VA Boston Healthcare System, Boston, MA, USA
Co-Chair: Mark Bustoros, MD – Meyer Cancer Center, Weill Cornell Medicine, Cornell University
Oral Abstract Session
Co-Chair: Masood A. Shammas, PhD – Dana Farber Cancer Institute and VA Boston Healthcare System, Boston, MA, USA
### @@@ Mark Bustoros, MD – Meyer Cancer Center, Weill Cornell Medicine, Cornell University ### 1395121###Co-Chair###Assistant Professor Of Medicine### Meyer Cancer Center, Weill Cornell Medicine, Cornell University###Co-Chair: Mark Bustoros, MD – Meyer Cancer Center, Weill Cornell Medicine, Cornell University
###Speaker: Kylee Maclachlan, MBChB, PhD – Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City NY, USA
Oral Abstract Session
Speaker: Kylee Maclachlan, MBChB, PhD – Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City NY, USA
###Speaker: Linda B. Baughn, PhD (she/her/hers) – Mayo Clinic, Rochester, MN, US
Oral Abstract Session
Speaker: Linda B. Baughn, PhD (she/her/hers) – Mayo Clinic, Rochester, MN, US
### she/her/hersSpeaker: Jiye Liu, PhD (he/him/his) – Dana-Farber Cancer Institute
Oral Abstract Session
Speaker: Jiye Liu, PhD (he/him/his) – Dana-Farber Cancer Institute
### he/him/hisSpeaker: Takahiro Kamiya, MD (he/him/his) – Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, The University of Tokyo, Tokyo, Japan / Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
Oral Abstract Session
Speaker: Takahiro Kamiya, MD (he/him/his) – Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, The University of Tokyo, Tokyo, Japan / Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
### he/him/hisSpeaker: Jian Cui – Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College
Oral Abstract Session
Speaker: Jian Cui – Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College
###Speaker: Paola Neri, MD PhD – Arnie Charbonneau Cancer Research Institute, University of Calgary
Speaker: Mehmet K. Samur, PhD – Dana-Farber Cancer Institute
Career Development
Speaker: Paola Neri, MD PhD – Arnie Charbonneau Cancer Research Institute, University of Calgary
### @@@ Mehmet K. Samur, PhD – Dana-Farber Cancer Institute ### 1395042###Speaker###Senior Research Scientist###Dana-Farber Cancer Institute###Speaker: Mehmet K. Samur, PhD – Dana-Farber Cancer Institute
###Speaker: Ajay K. Nooka, MD, MPH (he/him/his) – Winship Cancer Institute, Emory University School of Medicine
Speaker: Suzanne Trudel, MD – Princess Margaret Cancer Centre, Toronto, ON, Canada
Meet the Professor
Speaker: Ajay K. Nooka, MD, MPH (he/him/his) – Winship Cancer Institute, Emory University School of Medicine
### he/him/his @@@ Suzanne Trudel, MD – Princess Margaret Cancer Centre, Toronto, ON, Canada ### 1395092###Speaker###Professor of Medicine###Princess Margaret Cancer Centre, Toronto, ON, Canada###Speaker: Suzanne Trudel, MD – Princess Margaret Cancer Centre, Toronto, ON, Canada
###Speaker: Tanya Wildes, MD, MSCI (she/her/hers) – University of Nebraska Medical Center/Nebraska Medicine
Speaker: Raphael Szalat, MD; PhD (he/him/his) – Boston University Chobanian & Avedisian School of Medicine
Meet the Professor
Speaker: Tanya Wildes, MD, MSCI (she/her/hers) – University of Nebraska Medical Center/Nebraska Medicine
### she/her/hers @@@ Raphael Szalat, MD; PhD (he/him/his) – Boston University Chobanian & Avedisian School of Medicine ### 1442373###Speaker###Assistant professor of Medicine###Boston University Chobanian & Avedisian School of Medicine###Speaker: Raphael Szalat, MD; PhD (he/him/his) – Boston University Chobanian & Avedisian School of Medicine
### he/him/hisSpeaker: David Avigan, MD (he/him/his) – Beth Israel Deaconess Medical Center
Speaker: Heinz Ludwig, MD – Department of Medicine I, Wilhelminen Cancer Research Institute, Klinik Ottakring
Meet the Professor
Speaker: David Avigan, MD (he/him/his) – Beth Israel Deaconess Medical Center
### he/him/his @@@ Heinz Ludwig, MD – Department of Medicine I, Wilhelminen Cancer Research Institute, Klinik Ottakring ### 1442243###Speaker###Head of Institute###Department of Medicine I, Wilhelminen Cancer Research Institute, Klinik Ottakring###Speaker: Heinz Ludwig, MD – Department of Medicine I, Wilhelminen Cancer Research Institute, Klinik Ottakring
###Speaker: Mariateresa Fulciniti, PhD – Dana Farber Cancer Institute
Speaker: Niccolo Bolli, Prof. – University of Milan
Meet the Professor
Speaker: Mariateresa Fulciniti, PhD – Dana Farber Cancer Institute
### @@@ Niccolo Bolli, Prof. – University of Milan ### 1949887###Speaker###Associate Professor of Hematology###University of Milan###Speaker: Niccolo Bolli, Prof. – University of Milan
###Speaker: Constantine S. Mitsiades, MD, PhD – Dana Farber Cancer Institute
Speaker: Manoj Bhasin, PhD – Emory University
Meet the Professor
Speaker: Constantine S. Mitsiades, MD, PhD – Dana Farber Cancer Institute
### @@@ Manoj Bhasin, PhD – Emory University ### 1395127###Speaker###Director of Genomics, Proteomics, Bioinformatics and Systems Biology at Children’s Healthcare of Atlanta. ###Emory University###Speaker: Manoj Bhasin, PhD – Emory University
###Speaker: Samir Parekh, MD – Mount Sinai Medical Center, New York, NY, USA
Speaker: Brian A. Walker, PhD (he/him/his) – Indiana University
Meet the Professor
Speaker: Samir Parekh, MD – Mount Sinai Medical Center, New York, NY, USA
### @@@ Brian A. Walker, PhD (he/him/his) – Indiana University ### 1395036###Speaker###Professor###Indiana University###Speaker: Brian A. Walker, PhD (he/him/his) – Indiana University
### he/him/hisSpeaker: Prashant Kapoor, MD – Mayo Clinic
Speaker: Veronique Leblond, MD (she/her/hers) – Sorbonne Université
Meet the Professor
Speaker: Prashant Kapoor, MD – Mayo Clinic
### @@@ Veronique Leblond, MD (she/her/hers) – Sorbonne Université ### 1954265###Speaker###Professeur emerite###Sorbonne Université ###Speaker: Veronique Leblond, MD (she/her/hers) – Sorbonne Université
### she/her/hersCo-Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School
Co-Chair: Kenneth C. Anderson, MD – The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
General Session
Co-Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School
Co-Chair: Kenneth C. Anderson, MD – The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
General Session
Co-Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School
### @@@ Kenneth C. Anderson, MD – The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA ### 1395077###Co-Chair###Professor in Medicine###The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA###Co-Chair: Kenneth C. Anderson, MD – The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
###Speaker: Jens Lohr, MD, PhD – Dana-Farber Cancer Institute
General Session
Speaker: Jens Lohr, MD, PhD – Dana-Farber Cancer Institute
###Speaker: Raphael Szalat, MD; PhD (he/him/his) – Boston University Chobanian & Avedisian School of Medicine
Speaker: Raphael Szalat, MD; PhD (he/him/his) – Boston University Chobanian & Avedisian School of Medicine
### he/him/hisSpeaker: Flavia Pichiorri, PhD (she/her/hers) – City of Hope
General Session
Speaker: Flavia Pichiorri, PhD (she/her/hers) – City of Hope
### she/her/hersSpeaker: Marc-A. Baertsch, MD – German Cancer Research Center (DKFZ)
General Session
Speaker: Marc-A. Baertsch, MD – German Cancer Research Center (DKFZ)
###Chair: Jesus San Miguel, PhD. MD. (he/him/his) – Clínica Universidad de Navarra
Co-Chair: Noopur Raje, MD – Massachusetts General Hospital Cancer Center
General Session
Chair: Jesus San Miguel, PhD. MD. (he/him/his) – Clínica Universidad de Navarra
Co-Chair: Noopur Raje, MD – Massachusetts General Hospital Cancer Center
General Session
Chair: Jesus San Miguel, PhD. MD. (he/him/his) – Clínica Universidad de Navarra
### he/him/his @@@ Noopur Raje, MD – Massachusetts General Hospital Cancer Center ### 1395114###Co-Chair###Director, Center for Multiple Myeloma###Massachusetts General Hospital Cancer Center###Co-Chair: Noopur Raje, MD – Massachusetts General Hospital Cancer Center
###Speaker: Adam D Cohen, MD – Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
General Session
Speaker: Adam D Cohen, MD – Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
###Speaker: Niels van de Donk, MD PhD (he/him/his) – Amsterdam UMC
General Session
Speaker: Niels van de Donk, MD PhD (he/him/his) – Amsterdam UMC
### he/him/hisSpeaker: Krina K. Patel, MD (she/her/hers) – MD Anderson Cancer Center, University of Texas, Houston, TX, USA
General Session
Speaker: Krina K. Patel, MD (she/her/hers) – MD Anderson Cancer Center, University of Texas, Houston, TX, USA
### she/her/hersSpeaker: Joshua Richter, MD – Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
General Session
Speaker: Joshua Richter, MD – Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
###Speaker: Hui Liu, LH – Department of Hematology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, China
General Session
Speaker: Hui Liu, LH – Department of Hematology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, China
###Speaker: Luis-Esteban Tamariz-Amador, MD – Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), IdiSNA
General Session
Speaker: Luis-Esteban Tamariz-Amador, MD – Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), IdiSNA
###Speaker: Niels van de Donk, MD PhD (he/him/his) – Amsterdam UMC
General Session
Speaker: Niels van de Donk, MD PhD (he/him/his) – Amsterdam UMC
### he/him/hisSpeaker: Noopur Raje, MD – Massachusetts General Hospital Cancer Center
General Session
Speaker: Noopur Raje, MD – Massachusetts General Hospital Cancer Center
###Panelist: Jesus G. Berdeja, MD – Sarah Cannon Research Institute
Panelist: Ivan Borrello, MD – Tampa General Hospital
Panelist: Tom Martin, MD (he/him/his) – UCSF
Panelist: Monika Engelhardt
Panelist: Sham Mailankody, MBBS – Memorial Sloan Kettering Cancer Center
General Session
Panelist: Jesus G. Berdeja, MD – Sarah Cannon Research Institute
### @@@ Ivan Borrello, MD – Tampa General Hospital ### 1409073###Panelist###Director Multiple Myeloma, BMT and Cell Therapy###Tampa General Hospital###Panelist: Ivan Borrello, MD – Tampa General Hospital
### @@@ Tom Martin, MD (he/him/his) – UCSF ### 1949890###Panelist###Associate Chief, Hematology, Director Blood and Marrow Transplant and Cell Therapy###UCSF###Panelist: Tom Martin, MD (he/him/his) – UCSF
### he/him/his @@@ Monika Engelhardt ### 1949891###Panelist#########Panelist: Monika Engelhardt
### @@@ Sham Mailankody, MBBS – Memorial Sloan Kettering Cancer Center ### 1395111###Panelist###Associate Attending###Memorial Sloan Kettering Cancer Center###Panelist: Sham Mailankody, MBBS – Memorial Sloan Kettering Cancer Center
###Industry Symposium
Industry Symposium
Chair: Paul G. Richardson, MD – Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
###Speaker: Alessandra Larocca, MD, PhD – University of Torino
Industry Symposium
Speaker: Alessandra Larocca, MD, PhD – University of Torino
###Speaker: Yael C. Cohen, MD – Tel- Aviv Sourasky (Ichilov) Medical Center, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
Industry Symposium
Speaker: Yael C. Cohen, MD – Tel- Aviv Sourasky (Ichilov) Medical Center, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
###Speaker: Paul G. Richardson, MD – Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Industry Symposium
Speaker: Paul G. Richardson, MD – Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
###Speaker: Hang Quach, MBBS(Hons) SpecCertOC FRACP FRCPA MD – St Vincent’s Hospital Melbourne, University of Melbourne, VIC, Australia
Industry Symposium
Speaker: Hang Quach, MBBS(Hons) SpecCertOC FRACP FRCPA MD – St Vincent’s Hospital Melbourne, University of Melbourne, VIC, Australia
###Industry Symposium
Co-Chair: Robert Z. Orlowski, PhD, MD (he/him/his) – The University of Texas MD Anderson Cancer Center
Co-Chair: Qing Yi, MD, PhD (he/him/his) – Houston Methodist Neal Cancer Center
Oral Abstract Session
Co-Chair: Robert Z. Orlowski, PhD, MD (he/him/his) – The University of Texas MD Anderson Cancer Center
Co-Chair: Qing Yi, MD, PhD (he/him/his) – Houston Methodist Neal Cancer Center
Oral Abstract Session
Co-Chair: Robert Z. Orlowski, PhD, MD (he/him/his) – The University of Texas MD Anderson Cancer Center
### he/him/his @@@ Qing Yi, MD, PhD (he/him/his) – Houston Methodist Neal Cancer Center ### 1409108###Co-Chair###Associate Director###Houston Methodist Neal Cancer Center###Co-Chair: Qing Yi, MD, PhD (he/him/his) – Houston Methodist Neal Cancer Center
### he/him/hisSpeaker: Alejandro Medina-Herrera, PhD – Departamento de Hematología, Hospital Universitario de Salamanca, (HUSA/IBSAL), Centro de Investigación del Cáncer-IBMCC (CSIC/USAL), CIBERONC
Oral Abstract Session
Speaker: Alejandro Medina-Herrera, PhD – Departamento de Hematología, Hospital Universitario de Salamanca, (HUSA/IBSAL), Centro de Investigación del Cáncer-IBMCC (CSIC/USAL), CIBERONC
###Speaker: Samir Parekh, MD – Mount Sinai Medical Center, New York, NY, USA
Oral Abstract Session
Speaker: Samir Parekh, MD – Mount Sinai Medical Center, New York, NY, USA
###Speaker: Parvathi Sudha, MS (she/her/hers) – Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA
Oral Abstract Session
Speaker: Parvathi Sudha, MS (she/her/hers) – Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA
### she/her/hersSpeaker: Paola Neri, MD PhD – Arnie Charbonneau Cancer Research Institute, University of Calgary
Oral Abstract Session
Speaker: Paola Neri, MD PhD – Arnie Charbonneau Cancer Research Institute, University of Calgary
###Speaker: Carlos Fernandez de Larrea, MD, PhD – Hospital Clínic de Barcelona
Oral Abstract Session
Speaker: Carlos Fernandez de Larrea, MD, PhD – Hospital Clínic de Barcelona
###Speaker: Tom Martin, MD (he/him/his) – UCSF
### he/him/hisSpeaker: Philippe Moreau, MD – University Hospital Hôtel-Dieu, Nantes, France
Oral Abstract Session
Speaker: Philippe Moreau, MD – University Hospital Hôtel-Dieu, Nantes, France
###Speaker: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA
Oral Abstract Session
Speaker: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA
###Speaker: Maria-Victoria Mateos, PhD (she/her/hers) – University Hospital of Salamanca
Oral Abstract Session
Speaker: Maria-Victoria Mateos, PhD (she/her/hers) – University Hospital of Salamanca
### she/her/hersSpeaker: Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA
Oral Abstract Session
Speaker: Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA
### she/her/hersSpeaker: Noemi Puig, MD, PhD – Hospital Universitario de Salamanca, Instituto de investigación biomédica de Salamanca (IBSAL)
Oral Abstract Session
Speaker: Noemi Puig, MD, PhD – Hospital Universitario de Salamanca, Instituto de investigación biomédica de Salamanca (IBSAL)
###Speaker: Kenneth C. Anderson, MD – The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Oral Abstract Session
Speaker: Kenneth C. Anderson, MD – The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
###Co-Chair: Katja Weisel, MD (she/her/hers) – University Medical Center of Hamburg-Eppendorf, Hamburg, Germany
Co-Chair: Simon J. Harrison, MBBS, MRCP(uk), FRCPath(uk), FRACP, PhD (he/him/his) – Peter MacCallum Cancer Centre
Oral Abstract Session
Co-Chair: Katja Weisel, MD (she/her/hers) – University Medical Center of Hamburg-Eppendorf, Hamburg, Germany
Co-Chair: Simon J. Harrison, MBBS, MRCP(uk), FRCPath(uk), FRACP, PhD (he/him/his) – Peter MacCallum Cancer Centre
Oral Abstract Session
Co-Chair: Katja Weisel, MD (she/her/hers) – University Medical Center of Hamburg-Eppendorf, Hamburg, Germany
### she/her/hers @@@ Simon J. Harrison, MBBS, MRCP(uk), FRCPath(uk), FRACP, PhD (he/him/his) – Peter MacCallum Cancer Centre ### 1395103###Co-Chair###Director, Centre of Excellence in Cellular Immunotherapy###Peter MacCallum Cancer Centre###Co-Chair: Simon J. Harrison, MBBS, MRCP(uk), FRCPath(uk), FRACP, PhD (he/him/his) – Peter MacCallum Cancer Centre
### he/him/hisSpeaker: Simon J. Harrison, MBBS, MRCP(uk), FRCPath(uk), FRACP, PhD (he/him/his) – Peter MacCallum Cancer Centre
Oral Abstract Session
Speaker: Simon J. Harrison, MBBS, MRCP(uk), FRCPath(uk), FRACP, PhD (he/him/his) – Peter MacCallum Cancer Centre
### he/him/hisSpeaker: Shonali Midha, MD – Dana Farber Cancer Institute
Oral Abstract Session
Speaker: Shonali Midha, MD – Dana Farber Cancer Institute
###Speaker: Salomon Manier, MD, PhD – Centre Hospitalier Universitaire de Lille, Université de Lille, Lille, France
Oral Abstract Session
Speaker: Salomon Manier, MD, PhD – Centre Hospitalier Universitaire de Lille, Université de Lille, Lille, France
###Speaker: Jieyun Xia, MD – The Affiliated Hospital of Xuzhou Medical University
Oral Abstract Session
Speaker: Jieyun Xia, MD – The Affiliated Hospital of Xuzhou Medical University
###Speaker: Eyal Lebel, MD – Hadassah medical center
Oral Abstract Session
Speaker: Eyal Lebel, MD – Hadassah medical center
###Co-Chair: Eileen M. Boyle, MD PhD – UCL Cancer Institute
Co-Chair: Fanghuang Zhan, MD & PhD (he/him/his) – University of Arkasas Medical Sciences
Oral Abstract Session
Co-Chair: Eileen M. Boyle, MD PhD – UCL Cancer Institute
Co-Chair: Fanghuang Zhan, MD & PhD (he/him/his) – University of Arkasas Medical Sciences
Oral Abstract Session
Co-Chair: Eileen M. Boyle, MD PhD – UCL Cancer Institute
### @@@ Fanghuang Zhan, MD & PhD (he/him/his) – University of Arkasas Medical Sciences ### 1954267###Co-Chair###Professor###University of Arkasas Medical Sciences###Co-Chair: Fanghuang Zhan, MD & PhD (he/him/his) – University of Arkasas Medical Sciences
### he/him/hisSpeaker: Brian A. Walker, PhD (he/him/his) – Indiana University
Oral Abstract Session
Speaker: Brian A. Walker, PhD (he/him/his) – Indiana University
### he/him/hisSpeaker: Jessica Encinas Mayoral (she/her/hers) – Fundación Investigación Biomédica Hospital 12 de Octubre
Oral Abstract Session
Speaker: Jessica Encinas Mayoral (she/her/hers) – Fundación Investigación Biomédica Hospital 12 de Octubre
### she/her/hersSpeaker: Aintzane Zabaleta, PhD (she/her/hers) – CIMA (Pamplona)
Oral Abstract Session
Speaker: Aintzane Zabaleta, PhD (she/her/hers) – CIMA (Pamplona)
### she/her/hersSpeaker: Jian Cui – Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College
Oral Abstract Session
Speaker: Jian Cui – Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College
###Speaker: Ross S. Firestone, MD/PhD (he/him/his) – Memorial Sloan Kettering Cancer Center, New York City NY, USA
Oral Abstract Session
Speaker: Ross S. Firestone, MD/PhD (he/him/his) – Memorial Sloan Kettering Cancer Center, New York City NY, USA
### he/him/hisSpeaker: Jens Lohr, MD, PhD – Dana-Farber Cancer Institute
Speaker: Mattia D'Agostino, MD – University of Turin
Career Development
Speaker: Jens Lohr, MD, PhD – Dana-Farber Cancer Institute
### @@@ Mattia D'Agostino, MD – University of Turin ### 1949896###Speaker###Assistant professor###University of Turin###Speaker: Mattia D'Agostino, MD – University of Turin
###Speaker: Marta Sonia González, MD (she/her/hers) – H CLINICO UNIVERSITARIO SANTIAGO DE COMPOSTELA
Speaker: Claudio Cerchione, n/a (he/him/his) – Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy
Meet the Professor
Speaker: Marta Sonia González, MD (she/her/hers) – H CLINICO UNIVERSITARIO SANTIAGO DE COMPOSTELA
### she/her/hers @@@ Claudio Cerchione, n/a (he/him/his) – Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy ### 1661147###Speaker###Clinician###Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy###Speaker: Claudio Cerchione, n/a (he/him/his) – Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy
### he/him/hisSpeaker: Angela Dispenzieri, MD – Mayo Clinic Rochester
Speaker: Frits van Rhee, MD PHD (he/him/his) – Myeloma Center, University of Arkansas of Medicine
Meet the Professor
Speaker: Angela Dispenzieri, MD – Mayo Clinic Rochester
### @@@ Frits van Rhee, MD PHD (he/him/his) – Myeloma Center, University of Arkansas of Medicine ### 1954268###Speaker###Professor of Medicine###Myeloma Center, University of Arkansas of Medicine###Speaker: Frits van Rhee, MD PHD (he/him/his) – Myeloma Center, University of Arkansas of Medicine
### he/him/hisSpeaker: Dave Murray, MD PhD – Mayo Clinic
Speaker: Joan Bladé, MD PhD – Amyloidosis and Myeloma Unit. Hospital Clínic de Barcelona. IDIBAPS. University of Barcelona. Barcelona, Spain
Meet the Professor
Speaker: Dave Murray, MD PhD – Mayo Clinic
### @@@ Joan Bladé, MD PhD – Amyloidosis and Myeloma Unit. Hospital Clínic de Barcelona. IDIBAPS. University of Barcelona. Barcelona, Spain ### 1441772###Speaker###Hematologist###Amyloidosis and Myeloma Unit. Hospital Clínic de Barcelona. IDIBAPS. University of Barcelona. Barcelona, Spain###Speaker: Joan Bladé, MD PhD – Amyloidosis and Myeloma Unit. Hospital Clínic de Barcelona. IDIBAPS. University of Barcelona. Barcelona, Spain
###Speaker: Jorge J. Castillo, MD (he/him/his) – Dana-Farber Cancer Institute
Speaker: Andrew R. Branagan, MD, PhD – Massachusetts General Hospital
Meet the Professor
Speaker: Jorge J. Castillo, MD (he/him/his) – Dana-Farber Cancer Institute
### he/him/his @@@ Andrew R. Branagan, MD, PhD – Massachusetts General Hospital ### 1442194###Speaker###Attending Physician###Massachusetts General Hospital###Speaker: Andrew R. Branagan, MD, PhD – Massachusetts General Hospital
###Speaker: Meral Beksac, MD (she/her/hers) – Ankara University
Speaker: Natalie Callander, MD – University of Wisconsin
Meet the Professor
Speaker: Meral Beksac, MD (she/her/hers) – Ankara University
### she/her/hers @@@ Natalie Callander, MD – University of Wisconsin ### 1949893###Speaker###Director, Myeloma Clinical Program###University of Wisconsin###Speaker: Natalie Callander, MD – University of Wisconsin
###Speaker: Carlos Fernandez de Larrea, MD, PhD – Hospital Clínic de Barcelona
Speaker: Andrzej J. Jakubowiak, MD, PhD – University of Chicago, Chicago, IL, USA
Meet the Professor
Speaker: Carlos Fernandez de Larrea, MD, PhD – Hospital Clínic de Barcelona
### @@@ Andrzej J. Jakubowiak, MD, PhD – University of Chicago, Chicago, IL, USA ### 1409087###Speaker###Professor of Medicine; Director, Myeloma Program###University of Chicago, Chicago, IL, USA###Speaker: Andrzej J. Jakubowiak, MD, PhD – University of Chicago, Chicago, IL, USA
###Speaker: Karthik Ramasamy, MBBS FRCP FRCPath PhD – University of Oxford and Oxford University Hospitals NHS FT
Speaker: Dorotea Fantl, MD – Hospital Italiano de Buenos Aires, Argentina.
Meet the Professor
Speaker: Karthik Ramasamy, MBBS FRCP FRCPath PhD – University of Oxford and Oxford University Hospitals NHS FT
### @@@ Dorotea Fantl, MD – Hospital Italiano de Buenos Aires, Argentina. ### 1409082###Speaker###Consultant Physician in the Hematology Department of the Hospital Italiano de Buenos Aires ###Hospital Italiano de Buenos Aires, Argentina.###Speaker: Dorotea Fantl, MD – Hospital Italiano de Buenos Aires, Argentina.
###Co-Chair: MELETIOS DIMOPOULOS, MD (he/him/his) – Department of Clinical Therapeutics/Medical School/National and Kapodistrian University of Athens
Co-Chair: Efstathios Kastritis, MD, PhD (he/him/his) – National and Kapodistrian University of Athens
General Session
Co-Chair: MELETIOS DIMOPOULOS, MD (he/him/his) – Department of Clinical Therapeutics/Medical School/National and Kapodistrian University of Athens
Co-Chair: Efstathios Kastritis, MD, PhD (he/him/his) – National and Kapodistrian University of Athens
General Session
Co-Chair: MELETIOS DIMOPOULOS, MD (he/him/his) – Department of Clinical Therapeutics/Medical School/National and Kapodistrian University of Athens
### he/him/his @@@ Efstathios Kastritis, MD, PhD (he/him/his) – National and Kapodistrian University of Athens ### 1949897###Co-Chair###Professor of Medicine ###National and Kapodistrian University of Athens ###Co-Chair: Efstathios Kastritis, MD, PhD (he/him/his) – National and Kapodistrian University of Athens
### he/him/hisSpeaker: Steven Treon, MD, PhD, FACP, FRCP (he/him/his) – Dana Farber Cancer Institute
General Session
Speaker: Steven Treon, MD, PhD, FACP, FRCP (he/him/his) – Dana Farber Cancer Institute
### he/him/hisSpeaker: Vaishali Sanchorawala, MD (she/her/hers) – Boston University Chobanian & Avedisian School of Medicine
General Session
Speaker: Vaishali Sanchorawala, MD (she/her/hers) – Boston University Chobanian & Avedisian School of Medicine
### she/her/hersChair: Joseph Mikhael, MD – Translational Genomics Research Institute (TGen), City of Hope Cancer Center
Industry Symposium
Chair: Joseph Mikhael, MD – Translational Genomics Research Institute (TGen), City of Hope Cancer Center
Industry Symposium
Chair: Joseph Mikhael, MD – Translational Genomics Research Institute (TGen), City of Hope Cancer Center
###Speaker: Joseph Mikhael, MD – Translational Genomics Research Institute (TGen), City of Hope Cancer Center
Industry Symposium
Speaker: Joseph Mikhael, MD – Translational Genomics Research Institute (TGen), City of Hope Cancer Center
###Speaker: Xavier P. Leleu, MD, PhD (he/him/his) – Hospital La Mileterie, Poitiers, France
Industry Symposium
Speaker: Xavier P. Leleu, MD, PhD (he/him/his) – Hospital La Mileterie, Poitiers, France
### he/him/hisSpeaker: Fredrik Schjesvold, MD, PhD – Oslo Myeloma Center, Department of Hematology, Oslo University Hospital and KG Jebsen Center for B Cell Malignancies, University of Oslo
Industry Symposium
Speaker: Fredrik Schjesvold, MD, PhD – Oslo Myeloma Center, Department of Hematology, Oslo University Hospital and KG Jebsen Center for B Cell Malignancies, University of Oslo
###Speaker: Elizabeth O'Donnell, MD – Massachusetts General Hospital
Industry Symposium
Speaker: Elizabeth O'Donnell, MD – Massachusetts General Hospital
###Chair: Shaji K. Kumar, MD – Mayo Clinic, Rochester, MN, US
Co-Chair: Francesca Gay, MD – Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino
General Session
Chair: Shaji K. Kumar, MD – Mayo Clinic, Rochester, MN, US
Co-Chair: Francesca Gay, MD – Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino
General Session
Chair: Shaji K. Kumar, MD – Mayo Clinic, Rochester, MN, US
### @@@ Francesca Gay, MD – Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino ### 1441897###Co-Chair###Professor / Hematologist###Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino###Co-Chair: Francesca Gay, MD – Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino
###Speaker: Martin F. Kaiser, MD, FRCP, FRCPath – The Institute of Cancer Research; Royal Marsden Hospital
General Session
Speaker: Martin F. Kaiser, MD, FRCP, FRCPath – The Institute of Cancer Research; Royal Marsden Hospital
###Speaker: Moritz Binder, MD MPH (he/him/his) – Mayo Clinic
General Session
Speaker: Moritz Binder, MD MPH (he/him/his) – Mayo Clinic
### he/him/hisSpeaker: Laura Rosinol, MD, PhD (she/her/hers) – Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain
General Session
Speaker: Laura Rosinol, MD, PhD (she/her/hers) – Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain
### she/her/hersSpeaker: Salomon Manier, MD, PhD – Centre Hospitalier Universitaire de Lille, Université de Lille, Lille, France
General Session
Speaker: Salomon Manier, MD, PhD – Centre Hospitalier Universitaire de Lille, Université de Lille, Lille, France
###Speaker: Ioannis V Kostopoulos, n/a – Section of Animal and Human Physiology, Department of Biology, School of Sciences, National and Kapodistrian University of Athens, Athens, Greece
General Session
Speaker: Ioannis V Kostopoulos, n/a – Section of Animal and Human Physiology, Department of Biology, School of Sciences, National and Kapodistrian University of Athens, Athens, Greece
###Speaker: Clark DuMontier, MD, MPH (he/him/his) – VA Boston Healthcare System and Brigham and Women's Hospital/Harvard Medical School
General Session
Speaker: Clark DuMontier, MD, MPH (he/him/his) – VA Boston Healthcare System and Brigham and Women's Hospital/Harvard Medical School
### he/him/hisSpeaker: Hira Mian, MD, MSc, FRCPC – McMaster University, Hamilton, Ontario, Canada
General Session
Speaker: Hira Mian, MD, MSc, FRCPC – McMaster University, Hamilton, Ontario, Canada
###Speaker: Francesca Gay, MD – Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino
General Session
Speaker: Francesca Gay, MD – Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino
###Panelist: Wee Joo Chng, MB ChB, PhD, FRCP (UK), FRCPath (UK), FAMS – National University Cancer Institute, Singapore
Panelist: Sundar Jagannath, MD, FASCO – Mount Sinai Medical Center, New York, NY, USA
Panelist: Hira Mian, MD, MSc, FRCPC – McMaster University, Hamilton, Ontario, Canada
Panelist: Cristina Gasparetto, MD (she/her/hers) – Department of Medicine, Duke University Cancer Institute, Durham, NC
Panelist: Mohamad Mohty, MD, PhD – Sorbonne University, Saint-Antoine Hospital, AP-HP INSERM UMRs 938, Paris, France
General Session
Panelist: Wee Joo Chng, MB ChB, PhD, FRCP (UK), FRCPath (UK), FAMS – National University Cancer Institute, Singapore
### @@@ Sundar Jagannath, MD, FASCO – Mount Sinai Medical Center, New York, NY, USA ### 1395142###Panelist###Chair for Multiple Myeloma and Professor of Medicine###Mount Sinai Medical Center, New York, NY, USA###Panelist: Sundar Jagannath, MD, FASCO – Mount Sinai Medical Center, New York, NY, USA
### @@@ Hira Mian, MD, MSc, FRCPC – McMaster University, Hamilton, Ontario, Canada ### 1719006###Panelist###Assistant Professor###McMaster University, Hamilton, Ontario, Canada###Panelist: Hira Mian, MD, MSc, FRCPC – McMaster University, Hamilton, Ontario, Canada
### @@@ Cristina Gasparetto, MD (she/her/hers) – Department of Medicine, Duke University Cancer Institute, Durham, NC ### 1441876###Panelist###Professor of Medicine###Department of Medicine, Duke University Cancer Institute, Durham, NC###Panelist: Cristina Gasparetto, MD (she/her/hers) – Department of Medicine, Duke University Cancer Institute, Durham, NC
### she/her/hers @@@ Mohamad Mohty, MD, PhD – Sorbonne University, Saint-Antoine Hospital, AP-HP INSERM UMRs 938, Paris, France ### 1395090###Panelist###Professor of Hematology###Sorbonne University, Saint-Antoine Hospital, AP-HP INSERM UMRs 938, Paris, France###Panelist: Mohamad Mohty, MD, PhD – Sorbonne University, Saint-Antoine Hospital, AP-HP INSERM UMRs 938, Paris, France
###Speaker: Suzanne Lentzsch, MD, PhD (she/her/hers) – Columbia University
Speaker: Andrew R. Branagan, MD, PhD – Massachusetts General Hospital
Speaker: Ravi Vij, MD MBA – Washington University in St. Louis
Career Development
Speaker: Suzanne Lentzsch, MD, PhD (she/her/hers) – Columbia University
### she/her/hers @@@ Andrew R. Branagan, MD, PhD – Massachusetts General Hospital ### 1442194###Speaker###Attending Physician###Massachusetts General Hospital###Speaker: Andrew R. Branagan, MD, PhD – Massachusetts General Hospital
### @@@ Ravi Vij, MD MBA – Washington University in St. Louis ### 1395060###Speaker###Professor###Washington University in St. Louis###Speaker: Ravi Vij, MD MBA – Washington University in St. Louis
###